Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Liposarcoma × milademetan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 2 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Recurrence 1 Neoplasms 1 Mesothelioma 1 Melanoma 1 Lymphoma 1 Liposarcoma 1 Carcinoma, Renal Cell 1

Interventions

Trabectedin 4 Doxorubicin 3 brigimadlin 2 belinostat 2 Fulvestrant 2 Dexamethasone 2 toripalimab 1 tanespimycin 1 soblidotin 1 siremadlin 1 selinexor 1 ridaforolimus 1 ribociclib 1 pembrolizumab 1 olaratumab 1 milademetan 1 enzalutamide 1 cemiplimab 1 atezolizumab 1 TTI-621 1 Sugars 1 Midazolam 1 Letrozole 1 Imatinib Mesylate 1 Histamine H2 Antagonists 1 Fluorouracil 1 Famotidine 1 Docetaxel 1 Dacarbazine 1 Clinical Trials, Phase II as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04979442 2025-01-14

MANTRA

Rain Oncology Inc

Phase 3 Terminated

175 enrolled 16 charts

Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡